Healthcare-focused PE firm Somerset Indus Capital Exits Hexagon Nutrition

Somerset Indus Capital Partners, a private equity firm focused on healthcare in India, has sold its 10% stake in Hexagon Nutrition to undisclosed buyers.

In 2016, Somerset Indus invested Rs 25 crore in Hexagon Nutrition.

Read also- Pet Food Startup Dogsee Chew Raises $8Mn in Series B Funding Round

A person close to the development said, “The company is trying its luck again to go public, and they are looking to consolidate the investor base by providing them liquidity.” 

“It is a structured transaction so the entire consideration amount can’t be disclosed,” the spokesperson added. 

A structured transaction is a complex financial arrangement that uses different tools to achieve specific goals, such as managing risk, improving tax efficiency, or ensuring regulatory compliance.

Somerset Indus mainly invests in healthcare businesses serving Tier II and III cities and lower-income populations. The firm made six investments from its first fund, which closed in 2012 with $27 million. In 2019, it raised $76 million for its second fund. Somerset Indus is now raising around $250 million for its third fund, with the first close at $86 million last year.

About Hexagon Nutrition 

Hexagon Nutrition was founded in 1993, initially focusing on micronutrient formulations. Over time, it expanded into health, wellness, and clinical nutrition, becoming well-known for brands like Pentasure, Obesigo, and Pediagold.

Startup Funding News: Your Gateway to Every Funding Update.

Latest Startup News: Stay updated with the latest startup news and trends. Your go-to source for startup ecosystem updates.

Startup Stories: Discover inspiring tales of startups overcoming challenges and achieving success.